Clinical trial
Post-nasal Drainage as an Extraesophageal Manifestation of Reflux
NCT00199953 · Medical College of Wisconsin, Other · Completed
Key facts
| NCT number | NCT00199953 |
|---|---|
| Title | Post-nasal Drainage as an Extraesophageal Manifestation of Reflux |
| Official title | Post-nasal Drainage as an Extraesophageal Manifestation of Reflux |
| Lead sponsor | Medical College of Wisconsin, Other |
| Collaborators | Ortho-McNeil, Inc. Industry Eisai Inc. |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Postnasal Drainage |
| Intervention type | Drug |
| Interventions | Rabeprazole 20 mg twice a day for 90-day period treatment |
| Enrollment | 50 |
| Start date | Jun 1, 2002 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Jan 30, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: